Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aligos Therapeutics, Inc.

4.94
+0.31886.90%
Volume:55.41K
Turnover:268.17K
Market Cap:30.20M
PE:-0.24
High:5.05
Open:4.71
Low:4.55
Close:4.62
Loading ...
Nov 23, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 06, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Oct 18, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 09, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals